文献速递耳科与耳神经

Advanced Bionics 电极装置召回后早期故障风险与长期结局

Early Failure Risk and Long-Term Outcomes of Advanced Bionics Electrode Devices Post-Recall.
PubMed 文献 · Otolaryngol Head Neck Surg · 2025-10-17

该回顾性队列研究分析了2014年1月至2020年2月单中心植入的140例AB HiRes Ultra或Ultra 3D人工耳蜗,其中24例(17.1%)发生装置故障。中位故障时间3.6年,95%的故障发生在5.9年内,5年后年故障率降至2.1%。结论认为故障主要发生在植入后5年内,此后风险显著降低。

要点

  • AB人工耳蜗装置故障率为17.1%,中位故障时间3.6年。
  • 95%的故障发生在植入后5.9年内,5年后年故障率降至2.1%。
  • 故障与性别、年龄、种族或侧别无显著关联。

核心结论

  • AB人工耳蜗故障主要发生在植入后5年内,5年后风险显著降低,支持装置长期稳定性。

研究设计与样本

  • 回顾性队列研究,单中心三级学术医疗中心,纳入2014年1月至2020年2月植入AB HiRes Ultra或Ultra 3D人工耳蜗的140例装置。

主要发现

  • 140例AB植入中24例(17.1%)发生装置故障需翻修手术。
  • 中位故障时间3.6年(范围0.39-6.0年),中位随访5.2年(范围0.1-10.7年)。
  • 故障与性别、年龄、种族/民族或侧别无显著关联。
  • Kaplan-Meier分析显示95%的故障发生在最初5.9年内,5年后年故障率降至2.1%。

临床怎么用

  • 可依据5年内高风险、5年后低风险的特点进行患者咨询和制定随访方案。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To characterize the timing and likelihood of electrode failure in Advanced Bionics (AB) cochlear implants and assess long-term trends following the 2020 recall of HiRes Ultra and Ultra 3D models. STUDY DESIGN: Retrospective cohort study. SETTING: Single tertiary academic medical center. METHODS: We conducted a retrospective chart review of patients who received AB HiRes Ultra or Ultra 3D cochlear AB implants between January 2014 and February 2020. Patients who experienced device failure requiring revision surgery were identified. Demographics, implant date, failure status, and time to failure were recorded. Kaplan-Meier survival analysis was used to model cumulative failure risk over time. RESULTS: A total of 140 AB implants were placed, with 24 (17.1%) device failures identified. The median time to failure was 3.6 years (range: 0.39-6.0 years). Median follow-up was 5.2 years (range: 0.1-10.7 years). There was no significant association between failure and gender, age, race/ethnicity, or laterality. Kaplan-Meier analysis demonstrated that 95% of failures occurred within the first 5.9 years, and the failure rate decreased to 2.1% per year after 5 years. CONCLUSION: AB cochlear implant failures primarily occur within the first 5 years postimplantation, with significantly reduced risk beyond this period. These findings support long-term device stability and can inform patient counseling, expectations, and follow-up protocols.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Liu K, O'Brien L, Campbell D, et al. Early Failure Risk and Long-Term Outcomes of Advanced Bionics Electrode Devices Post-Recall. Otolaryngol Head Neck Surg. 2025. PMID: 41104824. doi:10.1002/ohn.70048

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。